Last reviewed · How we verify
gatifloxacin and moxifloxacin
gatifloxacin and moxifloxacin is a Small molecule drug developed by Donnenfeld, Eric, M.D.. It is currently in Phase 2 development. Also known as: Zymar and Vigamox.
At a glance
| Generic name | gatifloxacin and moxifloxacin |
|---|---|
| Also known as | Zymar and Vigamox |
| Sponsor | Donnenfeld, Eric, M.D. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse Events
- The Individualized M(X) Drug-resistant TB Treatment Strategy Study (PHASE4)
- Patients Response to Early Switch To Oral:Osteomyelitis Study (EARLY_PHASE1)
- Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis (PHASE3)
- Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin) (PHASE2)
- Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis (PHASE1, PHASE2)
- Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis
- Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- gatifloxacin and moxifloxacin CI brief — competitive landscape report
- gatifloxacin and moxifloxacin updates RSS · CI watch RSS
- Donnenfeld, Eric, M.D. portfolio CI
Frequently asked questions about gatifloxacin and moxifloxacin
What is gatifloxacin and moxifloxacin?
gatifloxacin and moxifloxacin is a Small molecule drug developed by Donnenfeld, Eric, M.D..
Who makes gatifloxacin and moxifloxacin?
gatifloxacin and moxifloxacin is developed by Donnenfeld, Eric, M.D. (see full Donnenfeld, Eric, M.D. pipeline at /company/donnenfeld-eric-m-d).
Is gatifloxacin and moxifloxacin also known as anything else?
gatifloxacin and moxifloxacin is also known as Zymar and Vigamox.
What development phase is gatifloxacin and moxifloxacin in?
gatifloxacin and moxifloxacin is in Phase 2.
Related
- Manufacturer: Donnenfeld, Eric, M.D. — full pipeline
- Also known as: Zymar and Vigamox
- Compare: gatifloxacin and moxifloxacin vs similar drugs
- Pricing: gatifloxacin and moxifloxacin cost, discount & access